Xtant Medical Holdings, Inc. (XTNT)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Total revenue | 35,411 | 32,904 | 27,937 | 29,943 |
| Cost of sales | 11,127 | 12,661 | 11,630 | 11,361 |
| Gross profit | 24,284 | 20,243 | 16,307 | 18,582 |
| Sales and marketing | 11,616 | 11,204 | 11,890 | 13,179 |
| Research and development | 566 | 443 | 701 | 636 |
| General and administrative | 7,478 | 7,533 | 7,493 | 7,713 |
| Total operating expenses | 19,660 | 19,180 | 20,084 | 21,528 |
| Income (loss) from operations | 4,624 | 1,063 | -3,777 | -2,946 |
| Other (expense) income | - | - | - | -5 |
| Other income (expense) | 7 | -9 | -13 | - |
| Interest expense | 1,004 | 1,045 | 1,199 | 992 |
| Unrealized foreign currency translation gain | 178 | 24 | 27 | 118 |
| Total other expense | -819 | -1,030 | -1,185 | -879 |
| Net income (loss) from operations before provision for income taxes | 3,805 | 33 | -4,962 | -3,825 |
| Provision for income taxes current and deferred | 255 | -25 | 62 | 36 |
| Net income (loss) | 3,550 | 58 | -5,024 | -3,861 |
| Basic | 0.03 | - | -0.04 | -0.03 |
| Basic | 139,310,589 | 139,068,831 | 135,100,233 | 130,269,710 |
| Dilutive | 0.02 | - | -0.04 | -0.03 |
| Dilutive | 148,574,242 | 143,335,114 | 135,100,233 | 130,269,710 |